Global S&T Development Trend Analysis Platform of Resources and Environment
DOI | 10.1038/s41467-017-02143-6 |
Targeting of dermal myofibroblasts through death receptor 5 arrests fibrosis in mouse models of scleroderma | |
Park, Jong-Sung1,2; Oh, Yumin1,2; Park, Yong Joo1,2; Park, Ogyi1,2,3; Yang, Hoseong4; Slania, Stephanie5; Hummers, Laura K.6; Shah, Ami A.6; An, Hyoung-Tae1,2; Jang, Jiyeon1,2; Horton, Maureen R.7; Shin, Joseph8; Dietz, Harry C.8; Song, Eric9; Na, Dong Hee10; Park, Eun Ji10; Kim, Kwangmeyung11; Lee, Kang Choon12; Roschke, Viktor V.3; Hanes, Justin2,5; Pomper, Martin G.1; Lee, Seulki1,2,13 | |
2019-03-08 | |
发表期刊 | NATURE COMMUNICATIONS |
ISSN | 2041-1723 |
出版年 | 2019 |
卷号 | 10 |
文章类型 | Article |
语种 | 英语 |
国家 | USA; South Korea |
英文摘要 | Scleroderma is an autoimmune rheumatic disorder accompanied by severe fibrosis in skin and other internal organs. During scleroderma progression, resident fibroblasts undergo activation and convert to alpha-smooth muscle actin (alpha-SMA) expressing myofibroblasts (MFBs) with increased capacity to synthesize collagens and fibrogenic components. Accordingly, MFBs are a major therapeutic target for fibrosis in scleroderma and treatment with blocking MFBs could produce anti-fibrotic effects. TLY012 is an engineered human TNF-related apoptosis-inducing ligand (TRAIL) which induces selective apoptosis in transformed cells expressing its cognate death receptors (DRs). Here we report that TLY012 selectively blocks activation of dermal fibroblasts and induces DR-mediated apoptosis in alpha-SMA(+) MFBs through upregulated DR5 during its activation. In vivo, TLY012 reverses established skin fibrosis to near-normal skin architecture in mouse models of scleroderma. Thus, the TRAIL pathway plays a critical role in tissue remodeling and targeting upregulated DR5 in alpha-SMA(+) MFBs is a viable therapy for fibrosis in scleroderma. |
领域 | 资源环境 |
收录类别 | SCI-E |
WOS记录号 | WOS:000460631100013 |
WOS关键词 | SYSTEMIC-SCLEROSIS ; ANTITUMOR-ACTIVITY ; STELLATE CELLS ; APOPTOSIS ; BETA ; EXPRESSION ; CHALLENGES ; RESISTANCE ; PATHWAYS |
WOS类目 | Multidisciplinary Sciences |
WOS研究方向 | Science & Technology - Other Topics |
URL | 查看原文 |
引用统计 | |
文献类型 | 期刊论文 |
条目标识符 | http://119.78.100.173/C666/handle/2XK7JSWQ/203627 |
专题 | 资源环境科学 |
作者单位 | 1.Johns Hopkins Univ, Sch Med, Russell H Morgan Dept Radiol & Radiol Sci, Baltimore, MD 21205 USA; 2.Johns Hopkins Univ, Sch Med, Wilmer Eye Inst, Ctr Nanomed, Baltimore, MD 21205 USA; 3.Theraly Fibrosis Inc, Germantown, MD 20876 USA; 4.Johns Hopkins Univ, Sch Med, Dept Dermatol, Baltimore, MD 21205 USA; 5.Johns Hopkins Univ, Sch Med, Dept Biomed Engn, Baltimore, MD 21205 USA; 6.Johns Hopkins Univ, Sch Med, Div Rheumatol, Scleroderma Ctr, Baltimore, MD 21224 USA; 7.Johns Hopkins Univ, Sch Med, Div Pulm & Crit Care Med, Baltimore, MD 21205 USA; 8.Johns Hopkins Univ, Sch Med, McKusick Nathans Inst Genet Med, Baltimore, MD 21205 USA; 9.Yale Univ, Sch Med, Dept Immunobiol, New Haven, CT 06520 USA; 10.Chung Ang Univ, Coll Pharm, Seoul 06974, South Korea; 11.Korea Inst Sci & Technol, Biomed Res Inst, Seoul 02792, South Korea; 12.Sungkyunkwan Univ, Sch Pharm, Suwon 16419, South Korea; 13.Johns Hopkins Univ, Dept Mat & Sci, Baltimore, MD 21218 USA |
推荐引用方式 GB/T 7714 | Park, Jong-Sung,Oh, Yumin,Park, Yong Joo,et al. Targeting of dermal myofibroblasts through death receptor 5 arrests fibrosis in mouse models of scleroderma[J]. NATURE COMMUNICATIONS,2019,10. |
APA | Park, Jong-Sung.,Oh, Yumin.,Park, Yong Joo.,Park, Ogyi.,Yang, Hoseong.,...&Lee, Seulki.(2019).Targeting of dermal myofibroblasts through death receptor 5 arrests fibrosis in mouse models of scleroderma.NATURE COMMUNICATIONS,10. |
MLA | Park, Jong-Sung,et al."Targeting of dermal myofibroblasts through death receptor 5 arrests fibrosis in mouse models of scleroderma".NATURE COMMUNICATIONS 10(2019). |
条目包含的文件 | 条目无相关文件。 |
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。
修改评论